SignalChem is a Canadian biotech company focused on the research, development and production of innovative and high-quality human recombinant cell signaling products. Throughout the years, Signalchem has capitalized on its core expertise in cellular signaling, molecular biology and protein biochemistry to generate more than 2,000 functional protein products and has established itself as the leader in industry to produce highly active human recombinant signaling enzymes, especially protein kinases, disease-related mutant kinases, lipid kinases, epigenetic enzymes, ubiquitination-related enzymes and neurodegenerative disease-related enzymes and proteins. SignalChem strives to support scientists in academia, pharma and biotech companies around the world by creating effective research tools to advance the basic research in life sciences and to facilitate the efforts in drug discovery and development.

SignalChem is also an world leader on custom development of cellular signalling proteins and compound selectivity profiling.